Will Ending the Medicaid Drug Rebate Cap Lower Drug Prices?

JAMA Intern Med. 2021 Aug 1;181(8):1034-1035. doi: 10.1001/jamainternmed.2021.2696.

Authors

Benjamin N Rome^{1

2}, Aaron S Kesselheim^{1

2}

Affiliations

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
² Harvard Medical School, Boston, Massachusetts.

PMID: 34180958
DOI: 10.1001/jamainternmed.2021.2696

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Costs* / legislation & jurisprudence
Drug Costs* / trends
Humans
Insurance, Pharmaceutical Services* / economics
Insurance, Pharmaceutical Services* / trends
Marketing
Medicaid / economics
Policy Making
Prescription Drugs / economics*
Prescription Fees
United States

Substances

Prescription Drugs